Labrina Barmpetaki, PIF President: “We’re not just asking for access to innovation — we’re asking for it to be properly valued and rewarded!” Pharma Innovation Forum at the Delphi Economic Forum 2026: Innovation in healthcare requires access, sustainability, and shared responsibility. Pharmaceutical innovation and especially the ability of the healthcare system to translate it into real access and value for…
The highest clawback in the EU, the suspension of innovative cancer therapies, the increasing delays in the arrival of new treatments, and disinvestment in innovation create a worrying environment that requires shared responsibility and immediate action. PhARMA Innovation Forum (PIF), representing 30 leading biopharmaceutical companies engaged in the research, development, and provision of innovative therapies,…
Innovation is not simply the introduction of new medicines. It is a catalyst that improves quality of life, reduces hospitalization and disability, and enhances productivity and societal participation. For Greece’s health system- already under pressure from demographic ageing, chronic disease burdens, and constrained budgets- innovative therapies and digital tools offer a path toward sustainability. They…
Daniel Paksy, Managing Director, Johnson & Johnson Innovative Medicine Greece & Romania In recent years, the word ‘innovation’ has become firmly embedded in almost every aspect of our daily lives. We hear it from scientists and business leaders across sectors, and it is often the standard answer when discussing progress and development. In pharmaceutical…
Anthony Aouad, Sanofi General Manager Greece, Hungary & Ukraine To understand what biopharmaceutical innovation truly means, let’s consider the moment when a patient, having heard the difficult news of diagnosis, asks the doctor: “Is there a treatment?” More and more today, the answer is “yes” – yes, there is a treatment that can change…
The advancement of biopharmaceutical innovation in Greece is crucial in shaping the future of health, significantly impacting patients’ lives, the economy, and the society. New technologies are transforming the way care is delivered, with the patient always at the center. The integration of tools such as telemedicine, electronic health records, health apps, and artificial intelligence…
Innovation in healthcare is not negotiable- it is life-saving. It transforms patient outcomes, strengthens health systems, and contributes to societal well-being. Today, a growing body of evidence confirms that better health drives economic growth. Innovative medicines keep people healthy and active, able to contribute to society. This is fundamental for a sustainable future, especially given…
In an era where scientific progress is accelerating at unprecedented rates, biopharmaceutical innovation is no longer simply a technological evolution. It constitutes a new pillar for health systems, with therapies that radically change the way rare diseases, cancer, hypercholesterolemia and an increasing range of chronic conditions are treated. Personalized medicine, gene interventions and pioneering molecules…
Einstein once said, ‘We cannot solve our problems with the same thinking we used when we created them’. This saying perhaps forms the very cornerstone- the beginning and the end- of pharmaceutical innovation: a continuous effort to seek new ways of thinking and approaching challenges, often beyond conventional limits, with the aim of providing definitive…
Pharma Innovation Forum at the Panhellenic Congress on Health Economics and Policy highlighted the critical role of data, evaluation, and European harmonization in modern pharmaceutical policy. Pharma Innovation Forum (PIF) had a strong institutional presence at the Panhellenic Congress on Health Economics and Policy, contributing substantially to the public discussion on how the country can…
